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Using Thermochromism to Simulate Blood 8 
Oxygenation in Extracorporeal Membrane 9 
Oxygenation 10 
Abstract 11 
Introduction: Extracorporeal membrane oxygenation (ECMO) training programs 12 
employ real ECMO components, causing them to be extremely expensive while 13 
offering little realism in terms of blood oxygenation and pressure. To overcome 14 
those limitations, we are developing a standalone modular ECMO simulator that 15 
reproduces ECMO’s visual, audio, and haptic cues using affordable 16 
mechanisms. We present a central component of this simulator capable of 17 
visually reproducing blood oxygenation color change using thermochromism. 18 
Methods: Our simulated ECMO circuit consists of two physically distant modules 19 
responsible for adding and withdrawing heat from a thermochromic fluid. This 20 
manipulation of heat creates a temperature difference between the fluid in the 21 
drainage line and the fluid in the return line of the circuit, and hence a color 22 
difference. 23 
Results: Thermochromic ink mixed with concentrated dyes was used to create a 24 
recipe for a realistic and affordable blood-colored fluid. The implemented “ECMO 25 
circuit” reproduced blood’s oxygenation and deoxygenation color difference or 26 
lack thereof. The heat control circuit costs 300 USD to build and the 27 
thermochromic fluid costs 40 USD/L. During a ten-hour in-situ demonstration, 28 
nineteen ECMO specialists rated the fidelity of the oxygenated and 29 
deoxygenated “blood” and the color contrast between them as highly realistic. 30 
  
 
Conclusions: Using low-cost yet high-fidelity simulation mechanisms, we 31 
implemented the central subsystem of our modular ECMO simulator which 32 
creates the look and feel of an ECMO circuit without using an actual one.  33 
 34 
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 39 
Introduction 40 
Among the many sophisticated pieces of technology found in the intensive care 41 
unit (ICU), the extracorporeal membrane oxygenation (ECMO) machine is arguably 42 
the most complex.1 It is used as an invasive life-sustaining device that provides 43 
cardiopulmonary support for patients during recovery of their diseased lung or 44 
heart or while awaiting for a transplant.2 Patients’ vital dependence on ECMO 45 
makes its uninterrupted and smooth operation of paramount importance. 46 
Unfortunately, ECMO is burdened with many complications caused by the patient’s 47 
pathology, mechanical failures of the equipment, or clinical error and inexperience 48 
of the clinical care team.3,4 ECMO’s vulnerability to human errors and its technically 49 
challenging nature requires ECMO practitioners to come equipped with adequate 50 
technical, behavioral, and crisis resource management skills.5 Since ECMO is a 51 
relatively low-volume and high-risk procedure that permits no room for learning 52 
from errors, training novice practitioners and maintaining competencies without 53 
compromising patients’ safety must preferably be done through simulation-based 54 
training (SBT).6–9 55 
Most ECMO centers offering SBT use different variations of the simulation 56 
model described by Anderson and her colleagues in 2006.10,11 The model consists 57 
of an ECMO circuit filled with red-colored saline and connected to itself through a 58 
reservoir (e.g. bladder) featuring a hidden connection to a syringe which facilitates 59 
circuit volume adjustment and injection of air.11 Emergency scenarios are 60 
simulated by discreet manual adjustments made to the circuit as the simulation 61 
session begins.11,12 For example, hypovolemia can be simulated by withdrawing 62 
fluid from the circuit while a confederate nurse sways a thread attached to the 63 
tubing to create shatters in the drainage line.11,12 64 
Although realistic from an equipment point of view, using an ECMO circuit 65 
and machine for simulation purposes has major drawbacks. First, many simulated 66 
emergency scenarios are detached from reality or require trainees to imagine and 67 
  
 
pretend. In an oxygenator failure scenario, for example, it is not possible to 68 
increase the delta-pressure across the oxygenator, produce deoxygenated blood 69 
color in the return line, or manipulate blood gas saturations displayed on modern 70 
ECMO consoles or in-line monitors without complex circuit modifications or using 71 
real blood. Many other scenarios suffer from the same issue, which is mainly 72 
caused by the simulator’s inability to control circuit and blood parameters, or 73 
reproduce relevant visual/audio cues. Some commercial ECMO simulators address 74 
some of those issues by providing instructors with a wirelessly controlled screen to 75 
display relevant parameters.13,14 Still, there remains a disconnect between the 76 
parameters that are displayed on the real ECMO system and the ones displayed 77 
on the emulated screens. Second, disposable ECMO circuit components such as 78 
the oxygenation membrane, are expensive, making continuous replacement for 79 
training purposes limiting or prohibitive.15  80 
Motivated by the aforementioned drawbacks, we are developing a 81 
standalone ECMO simulator that does not require the presence of a real ECMO 82 
machine or its expensive circuit components. The core principle is to recreate an 83 
ICU ECMO environment which instructors can fully and remotely control and 84 
learners can interact with. This is done by designing affordable but high-fidelity 85 
modules capable of reproducing ECMO visual, audio, and tactile cues (e.g. blood 86 
color, air entry pump noise, and line-shattering) without their physical or 87 
physiological requirements.16,17 These modules are then enclosed within 3D 88 
printed cases that resemble real ICU or ECMO components. Naturally, our initial 89 
development efforts were drawn to simulating the most observable and indicative 90 
ECMO visual cue: blood oxygenation color change. Blood color transitions from 91 
dark-red to red as it gains oxygen () and loses carbon dioxide (). It is a 92 
critical diagnostic tool that indicates normal operation, successful ECMO initiation, 93 
low-oxygen saturation in the return line, and recirculation. This article describes the 94 
use of thermochromism in the development of the oxygenation and deoxygenation 95 
modules used in our ECMO simulator with the objective of reproducing a realistic 96 
oxygenated-deoxygenated blood color difference and building a standalone 97 
“ECMO circuit”. 98 
 99 
Methods 100 
Thermochromism is a property of a substance that allows reversible color change 101 
with temperature. Thermochromic inks and powders are products designed to 102 
transition between two distinct states (colors) above and below a fixed transition 103 
temperature ().18 Our simulated ECMO circuit exploits this property by circulating 104 
a thermochromic fluid (diluted thermochormic ink mixed with other dyes) through 105 
two physically-distant modules responsible for adding or withdrawing thermic 106 
energy (heat). Heat manipulations drive temperature change in the fluid, triggering 107 
it to change state. The circuit design is presented in Figure 1. Besides the “patient” 108 
  
 
location sits a reservoir containing the thermochromic fluid that is pumped through 109 
a heat exchanger (HE), cooling it below its . On the opposite side of the circuit, a 110 
3D printed “oxygenator” conceals the bypassing of the fluid to another HE, which 111 
heats it above its . The continuous change of the fluid temperature—in two 112 
separate locations—creates a noticeable color difference pre-and-post oxygenator 113 
(and pre-and-post patient), hence simulating observable blood oxygenation color 114 
difference. 115 
 116 
 117 
Figure 1: Simulated ECMO circuit design. 118 
 119 
Thermochromic Fluid 120 
Many fluid colors can be achieved by mixing thermochromic inks with other 121 
variants or coloring products. Our aim was to find an affordable, yet optimal mixture 122 
that visually resembles blood. Initially, red and black thermochromic inks (SFXC, 123 
East Sussex, UK) were mixed and diluted in distilled water. Considering that the 124 
black thermochromic ink becomes invisible when heated to 31∘C, the premise was 125 
  
 
for the black thermochrome to be cooled to introduce a dark tint onto the red and 126 
heated to eliminate itself, creating a dark-red to red color difference. Unfortunately, 127 
diluting the inks in water caused a subtle gray-shift in their colors (black → gray, 128 
and red → pink) resulting in a purple to pink thermochromic fluid. An attempt to 129 
color-correct the purple into red was pursued by mixing in yellow and red 130 
concentrated dyes (Mayhems Solutions, Darlington, UK). However, it proved 131 
impractical as it was necessary to add large amounts of dye to make a noticeable 132 
difference, raising the overall cost of the simulated blood. This was addressed by 133 
eliminating the red thermochromic ink from the mixture, allowing lower amounts of 134 
dye to produce a more potent effect. Diluting the ink in water was also observed to 135 
cause the black ink to change state between 27∘C to 32∘C rather than the 136 
advertised 31	°C. This temperature transition region was kept in mind during the 137 
design process of the circuit. The final fluid recipe is presented in Results.  138 
 139 
Heat Exchange 140 
Each of the two modules contains a plate heat exchanger (PHE) chosen on the 141 
virtue of its compactness and efficiency. PHEs take two liquid streams (primary 142 
and secondary) and facilitate heat transfer from the hot stream to the colder one 143 
through thermal conductive plates. In both modules, the primary stream is the 144 
thermochromic fluid and the secondary stream is hot or cold water supplied by a 145 
heater-cooler machine. The aim of this section is to describe the selection of a flow 146 
rate for the primary stream and flow rates and temperatures for the secondary 147 
streams which will result in a sufficient (thermochromic state-altering), balanced 148 
(between the two modules), and bounded (by the capacity of the heater-cooler 149 
machine) heat exchange process. 150 
The relationship between the heat exchanged between the two streams, 151 
their input temperatures, and their flow rates is summarized in (1).19 Where  is the 152 
heat transferred between the two streams (in W),  and  are, respectively, the 153 
fluid’s temperature into and out of the HE (in °C),  is the fluid’s flow rate (in L/min), 154  is the heat exchange coefficient (in W×	m 	× °C), and  is the heat exchange 155 
area (in m). The subscripts ℎ and  are used to refer to the warmer or colder 156 
streams with respect to the other as seen at the input of the HE (i.e. the 157 
thermochromic fluid is considered a hot stream when compared to cold water and 158 
a cold stream when compared to hot water). 159 
 = , − ", 
 =  + 60 4180  
 
(1) 
  
 
	 =   − [*, +
60 +−,4180 - − .", + 60 Q4180 "0]
	ln+, − ln+[*, + 60 +−,4180  - − .", + 60 Q4180 "0],
 
Since the final equation in (1) is non-linear and has many variables, an 160 
iterative empirical approach is used to determine the appropriate temperature and 161 
flow rate values. The procedure is applied per module and is as follows: 162 
1. Select a PHE and find the constant  using its physical properties and 163 
properties of distilled water.20 164 
2. Select an operational temperature range for the thermochromic fluid. 165 
Estimate the initial temperature values allowed into the tank before the 166 
system startup (common to both modules). 167 
3. Assume a flow rate for the thermochromic fluid (common to both modules). 168 
4. Assume a temperature and flow rate for the secondary stream (hot or cold 169 
water depending on the module). This is typically found in the heater-cooler 170 
machine specifications. 171 
5. Find  using a non-linear solver such as MATLAB’s fsolve() function. 172 
6. Check if  causes sufficient temperature change to output the desired 173 
thermochromic state (in this case  < 27 when cooling and  > 32 174 
when heating). 175 
7. Check if the maximum  transferred is within the heating/cooling capacity of 176 
the heater cooler-machine. 177 
8. Repeat steps 3, 4, and 5 until 6 and 7 are met. 178 
 179 
Circulation and Flow Control 180 
This section aids in the pump selection process by describing the estimation 181 
method of the required pump head. Head is the positive pressure, exerted on a 182 
liquid, required to overcome the flow resistance caused by circuit components 183 
(tube and HEs, in-line sensors, etc.). 184 
The tube-generated head is described in (2), where 6 is the tube’s head (in 185 
m), 7
 
is the tube’s friction coefficient, 8 is the tube’s length (in m), and 9 is the tube 186 
inner diameter (in m).21
 
The friction coefficient depends on the tube’s wall material 187 
and (3) provides an estimation based on the use of polyvinyl chloride (PVC) tubes, 188 
where :; is the circuit Reynolds number. The additional head generated by other 189 
components (HEs, in-line sensors, etc.) can be found in the corresponding 190 
component’s specifications sheet. 191 
  
 
6 ≈ 2.2975	λ 810AA 9B  (2) 
7 ≈
CD
E64:; , if	:; < 2000
[−2logAJ * 2.51:;√7 +
0.00153700 9-], if	:; ≥ 2000
 
:; ≈ 0.037605 9 
 
(3) 
Running any pump at a constant rotation per minute (RPM) will produce a 192 
flow rate proportional to the flow resistance of the circuit it is connected to. In 193 
ECMO, the circuit flow resistance changes significantly based on the patient’s size, 194 
age group, and the health condition of the veins and arteries. Hence to maintain 195 
the flow rate required for sufficient heat exchange, the pump’s RPM requires 196 
continuous adjustment. Fortunately, brushless direct-current (BLDC) motor pumps 197 
are easy to control, readily available, and inexpensive. A metal-oxide-198 
semiconductor field-effect transistor (MOSFET) can act as a variable electric 199 
current “valve” when placed in series with the pump’s power source. In this 200 
implementation, a microcontroller reads the flow rate from a flowmeter and 201 
subsequently controls the current that goes through the MOSFET. This results in 202 
more or less electric current reaching the pump, hence, varying its power and RPM 203 
to maintain the circuit’s flow rate. 204 
 205 
Thermochromic Circuit Design 206 
Following the design procedure outlined in the previous section, the HXP-193 207 
(Koolance, Auburn, WA) was the selected PHE used to heat and cool the 208 
thermochromic fluid above and below the aforementioned transition region. The 209 
PHE’s  constant was calculated as (433	 W°C) and the thermochromic fluid 210 
operational temperature range was set from 21	∘C to 40	∘C and the secondary 211 
streams values (temperature and flow rate) were bound by the Sorin 3T (LivaNova, 212 
London, England) heater-cooler available in our partner hospital. The resultant 213 
configuration is as follows: 214 
• Thermochromic flow rate: ≤ 1.6	L/min 215 
• Cold water: 25	∘C at 15	L/min (Sorin 3T patient circuit) 216 
  
 
• Hot water: 35	∘C at 9	L/min (Sorin 3T cardioplegia circuit) 217 
Using the maximum thermochromic fluid flow rate (1.6	L L/min) and the 3/8” 218 
polyvinyl chloride (PVC) tube used in our circuit, 7 was estimated to be 0.0388. 219 
Consequently, the total circuit head considering a 10	m tube, two heat-exchangers, 220 
and a flow sensor is 0.5 m. Koolance’s PMP-300 (Koolance, Auburn, WA) BLDC 221 
pump was selected since it offers head up to 2.6	m. It was controlled by a Teensy 222 
3.2 microcontroller (PJRC, Sherwood, OR) with feedback from an INS-FM14 223 
(Koolance, Auburn, WA) flow meter. 224 
 225 
Assessment 226 
The thermochromic fluid color-temperature characteristics were quantified using a 227 
digital camera (Canon EOS 600D, Canon, Tokyo, Japan). Cold thermochromic 228 
fluid was filled in a beaker and placed on top of a hot plate to vary its temperature. 229 
A camera was fixed 50	cm away looking down into the beaker +≈ 10∘ −230 20∘ clockwise) to minimize reflection. Pictures were taken under cool-white 231 
fluorescent lighting (≈ 4100	K) and the camera’s exposure was fixed with the help 232 
of a luminance histogram. To reproduce colors correctly, the photos were digitally 233 
white balanced using an objective technique.22 Then, ten-pixel points were 234 
sampled from the fluid’s surface and the average of the pixels’ standard Red-235 
Green-Blue (sRBG) components was considered the quantified color. 236 
The circuit was implemented and tested with a convenience sample of 237 
ECMO clinicians from Hamad Medical Corporation (HMC), our partner hospital. 238 
Nineteen participants from different professions (physicians, perfusionists, nurses, 239 
and respiratory therapists) evaluated the thermochromic effect. They, on average, 240 
had 4.73	+0.5 − 12, years of ECMO experience and had cared for an average of  241 75	+3 − 150, ECMO patients each. The demographics are summarized in Table 1. 242 
Participants were introduced to the circuit and were asked to fill in a questionnaire 243 
that included a set of statements about the realism of the “blood” color in its 244 
oxygenated and deoxygenated states along with the contrast between the two 245 
states using a 5-point Likert scale (1=not realistic at all; 5=very realistic). 246 
To assess the thermochromic fluid consumability, samples were taken from 247 
the circuit’s reservoir every two hours of the circuit’s operation as the fluid was 248 
continuously circulating through the cooling and heating system. Samples’ ink 249 
concentration was estimated using a calibrated 400NO absorbance versus 250 
concentration plot.  251 
Table 1: Demographic characteristics of evaluation participants. 252 
  
 
 
N+%, 
Gender  
Male 14 +73.6%, 
Female 5 +26.4%, 
Age (years)  
25 – 34 4 +21%, 
35 – 44 9 +47%, 
45 – 54 4 +21%, 
55 – 64 2 +11%, 
Profession  
Physician 5 +26.4%, 
Perfusionist 5 +26.4%, 
Nurse 8 +42.1%, 
Respiratory therapist 1 +5.1%, 
 Mean (±std) 
ECMO experience (years) 4.7 +±3.2, 
Number of patients cared 
for 
75 +±52, 
 253 
Ethics 254 
The clinicians’ evaluation aspect of this research project was approved by HMC’s 255 
Medical Research Center (#17231/17) and classified as “exempt” from full ethical 256 
review. 257 
 258 
 259 
Results 260 
Thermochromic Fluid 261 
As outlined in Methods, thermochromic ink enables achieving a variety of possible 262 
color variants. Our final recipe consisted of black thermochromic ink with red and 263 
yellow concentrate dyes. The ink was first diluted in distilled water to obtain the 264 
desired concentration. Afterwards, the volume of dyes is determined proportional to 265 
the ink’s weight. Figures 2A and 2B show, respectively, how fluid temperature and 266 
ink concentration affect the color of the mixture. The ink’s concentration was kept 267 
constant during temperature variations and vice-versa with the dyes’ concentration 268 
always proportional to the ink’s weight.  269 
sRGB components of the quantified color bars in Figures 2A and 2B are 270 
plotted in Figure 3 where the ink temperature transition region can be clearly 271 
  
 
observed. Moreover, we found that concentrations lower than 13	mg/mL were too 272 
translucent, and hence a black thermochromic ink of that concentration or higher 273 
was considered visually acceptable. 274 
 275 
Figure 2: Thermochromic fluid final recipe. (A) The fluid recipe varied over the 276 
selected operational temperature range at a fixed concentration (B) The fluid recipe 277 
varied over thermochromic ink concentrations. 278 
 279 
  
 
 280 
Figure 3: Quantified standard red green blue (sRGB) components. (A) sRGB 281 
against temperature variation. (B) sRGB against concentration. 282 
 283 
Circuit Implementation 284 
The circuit described in Methods was setup in an intensive care unit at HMC as 285 
seen in Figure 4. A prototype mock-up of Maquet’s HLS oxygenator (Maquet, 286 
Rastatt, Germany) was 3D printed and used to discreetly bypass the liquid to the 287 
oxygenation module (heating unit) and receive it after heating via an opaque PVC 288 
tube. The circuit produced three distinct color visual effects as seen in Figure 5: 289 
  
 
blood oxygenation and deoxygenation, low-oxygen saturation in the return line, and 290 
high-oxygen saturation in the drainage line. 291 
 292 
Figure 4: Simulated “ECMO circuit'' setup in an ICU. 293 
 294 
Figure 5: Simulated “ECMO circuit'' in its three states. (A) Blood oxygenation and 295 
deoxygenation. (B) Low oxygen saturation in return line. (C) High oxygen 296 
saturation in the drainage line. 297 
  
 
The mean rating (out of 5) for oxygenated and deoxygenated blood color realism, 298 
and realism of their contrast were 4.63, 4.79, and 4.53 respectively. Table 2 299 
summarizes the results. Over the period of ten hours, five samples of the 300 
thermochromic fluid were taken from the reservoir and their concentration was 301 
measured. Using a linear fit, we found that the fluid degrades by a 0.38 mg/mL 302 
(: = 0.84) per hour. Between the tenth and eleventh hours of operation, the 303 
thermochromic fluid failed whereby the black thermochromic ink stopped 304 
transitioning when heated. None of the participants witnessed the thermochromic 305 
fluid in its non-functioning state. 306 
Table 2: Results descriptive statistics 307 
Sample size n = 19 
Oxygenated “Blood” 
Color Realism 
Mean = 4.63 +±0.482, 
Min = 4.00 
Max = 5.00 
 
Mode = 5.00 
Median = 5.00 
Deoxygenated “Blood” 
Color Realism 
Mean = 4.79 +±0.408, 
Min = 5.00 
Max = 4.00 
 
Mode = 5.00 
Median = 5.00 
“Blood” Color Contrast 
Realism 
Mean = 4.53 +±0.595, 
Min = 3.00 
Max = 5.00 
 
Mode = 5.00 
Median = 5.00 
 308 
Discussion 309 
High-fidelity simulation sessions aid in achieving suspension of disbelief in trainees 310 
and prevent negative learning, a key to successful SBT.24,25 However, high-fidelity 311 
systems and environments are costly and require a significant financial 312 
commitment.26 This is exacerbated with the currently used ECMO SBT 313 
  
 
approaches. On top of simulation equipment, ECMO centers that offer SBT also 314 
rely on a functioning ECMO machine alongside expensive consumable circuit 315 
components which offer little in terms of context because the visual/audio cues 316 
they produce and parameters they display are generally inconsistent or 317 
uncontrollable in relation to enacted scenarios. 318 
We sought to address the limitations of the ECMO simulation paradigm by 319 
developing a standalone and modular ECMO simulator. In this article, we 320 
demonstrated the design and implementation of a patented simulated “ECMO 321 
circuit” featuring a unique thermochromic effect that resembles blood oxygenation 322 
color change in real ECMO circuits27. The circuit operates on a balanced and 323 
continuous heat exchange process, producing a temperature difference between 324 
the drainage and return lines, and hence a color difference due to 325 
thermochromism. It can create visual cues relevant to many emergency scenarios 326 
including oxygenator failure, disconnected gas supply, increased oxygen 327 
consumption, decreased lung function, inadequate circuit flow, and recirculation. 328 
Nineteen clinicians specializing in ECMO at HMC with varying degrees of 329 
experience evaluated the fidelity of the thermochromic effect. On average, the 330 
participant rated the effect as highly realistic. The common criticism received was 331 
that the oxygenated and deoxygenated “blood” colors were too dark and should be 332 
slightly brighter and redder, which can be corrected by changing the concentration 333 
of dyes and ink in the fluid mixture. 334 
Advantages of an ECMO independent simulator with a modular design 335 
approach are the reduced deployment and maintenance cost, customizability and 336 
expandability, and full system control. The simulated blood color change circuit 337 
components (excluding the heater-cooler) costs 300 USD to build and can be used 338 
indefinitely (or until a component is damaged) since components are non-339 
consumable. Our thermochromic recipe costs 40 USD/L with a low (0.38 mg/mL) 340 
concentration degradation over time and an operational lifetime of ten hours. It is 341 
up to the user to determine whether circuit component costs and the fluid’s realism, 342 
cost, and lifetime is acceptable as every component used in the circuit can be 343 
substituted by other brands and there are many possible recipes due to the broad 344 
selection of thermochromes and dyes in the market. Moreover, our in-house design 345 
facilitates ease of use and control since the system electronics are programmable 346 
to the user’s preference and can be wirelessly enabled to receive remote 347 
commands to perform simulation actions. Overall, many of the existing ECMO 348 
related SBT programs could greatly benefit from this innovation to further enhance 349 
their participants’ learning.24 350 
This study has several limitations. First, we had no access to quantitative 351 
color-measuring tools, limiting the color quantification to a digital camera, where it 352 
can vary based on the illuminance and the camera exposure settings. We 353 
  
 
attempted to mitigate this weakness by (i) presenting photos of the fluid in two 354 
different environments and illuminants (in-lab and in-situ); (ii) using the camera’s 355 
luminance histogram to make sure the exposure is set in the middle (not too dark 356 
or too bright); and (iii) surveying ECMO specialists about the realism of the color. 357 
Second, our assessment of the circuit’s efficacy is limited by the prototypic nature 358 
of the implementation. Thus, our design can only be truly assessed when the 359 
system is complete with a “product level” quality and is compared head to head 360 
with the traditional simulation method. Finally, the realism of the simulator is highly 361 
dependent on the fidelity of our 3D printed components and casings and how well 362 
we can integrate the modules into the ICU environment. Future work includes 363 
obtaining a thermochromic fluid with longer operational time and establishing a 364 
dynamic relationship between simulated blood color and various ECMO 365 
parameters such as hemoglobin and oxygen saturation. 366 
 367 
Conclusions 368 
A novel system consisting of modules that work together to reproduce ECMO’s 369 
visual, audio, and haptic cues is proposed. In this article, we presented the use of a 370 
low-cost but high-fidelity technology in the design of two modules responsible of 371 
creating a simulated ECMO circuit with the ability to reproduce ECMO’s blood 372 
oxygenation visual cue (or the lack thereof) using the thermochromism properties 373 
of a fluid mixture. The two modules work together to create a temperature 374 
difference between the drainage and return lines of the “ECMO circuit”, resulting in 375 
a color difference. ECMO practitioners found the circuit highly realistic and they 376 
could easily distinguish the two colors of the simulated blood. 377 
We envision that, after completion, our modular ECMO simulator will feature 378 
more simulated ECMO cues including drainage line vibrations (line-shattering), 379 
patient bleeding, air noise in the pump head, blood oxygenator clotting, and others. 380 
Those modules will be wirelessly connected to a tablet application, giving 381 
instructors full control of the ECMO environment and facilitating the creation of 382 
high-fidelity and immersive simulation scenarios. 383 
  384 
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